Remote monitoring for adults with depression using ThIA Suivi
Official title: Evaluation of the Clinical Efficacy of a New Strategy for Managing Patients With Depression Using an Innovative Remote Medical Monitoring System
Run by ThIA Santé Mentale · NCT07878754 · Data updated 2026-11-12
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 608 (estimated) |
| Sponsor | ThIA Santé Mentale Industry-sponsored |
| Locations | 3 sites (Bron and 2 other locations) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT07878754 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a PHQ-9 score of 15 or higher and a confirmed depression diagnosis, under the care of the investigator, with internet access and able to participate in a French-language protocol.
✕Probably not a fit
Persons without access to or ability to use the digital monitoring tool, or without sustained engagement in remote monitoring, may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional phase 1 trial evaluates ThIA Suivi, a digital remote-monitoring device, in adults with diagnosed depression. Participants continue their regular psychiatric care while either using the ThIA Suivi tool or receiving usual care. The primary outcome is the share of patients with a clinically meaningful improvement in depression symptoms, defined as a 5-point or greater reduction on the PHQ-9 after 3 months. Questionnaires track symptom changes over time, and safety and adherence are monitored. The study is conducted under real-world clinical supervision at multiple French centers.
Why it matters
Potential benefit: If successful, patients could experience greater symptom improvement through enhanced, continuous monitoring and timely interventions.
How similar studies have gone: Prior similar digital-mental-health monitoring approaches have shown potential benefits in symptom management, but results vary by setting and population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a PHQ-9 score of ≥ 15 and a confirmed diagnosis of depression * Patients under the care of the investigator; * Patients who have not received any treatment for at least 6 weeks and to whom the investigator prescribes an antidepressant. * Patients with a smartphone, computer or tablet with internet access; * Patients covered by a health insurance scheme; * Patients able to read and understand French; * Patients who have signed a written, informed consent form in person to take part in the study. Exclusion Criteria: * Patients under guardianship, curatorship or judicial protection, or subject to any other administrative or judicial measure resulting in the deprivation of rights and freedoms; * Patients with neurocognitive disorders or psychiatric conditions (e.g. psychotic disorders, cognitive impairments or manic states) that may compromise their ability to give free and informed consent and/or to comply with the study protocol; * Patients at imminent risk of suicide or with severe depression accompanied by psychotic symptoms; * Patients deemed non-autonomous by the psychiatrist, i.e. those who, according to clinical assessment, are unable to manage their daily activities independently or lack sound judgement; * Patients already enrolled in another interventional study * Vulnerable persons as defined in Articles L. 1121-5 to 8 and L. 1122-1-2 of the French Public Health Code are excluded from the study.
Where it's running
-
Centre Hospitalier Le Vinatier
Bron, France Recruiting -
Hôpital Novo
Pontoise, France Recruiting -
Hôpital Uzès - Le Mas Careiron Secteur 30G07 - CMP de Saint Hippolyte du Fort
Uzès, France Recruiting
Study contacts
- Study coordinator: Nicolas Desrumaux, PhD
- Email: admin@digitalmedicalhub.com
- Phone: 0033684979459
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep-to-Mood in Depression: Home-based tDCS
This study tests whether home-based tDCS for adults with moderate depression helps sleep improve and whether better sleep is linked to mood improvements.
-
Heated yoga, sauna, or a mindfulness app for depression
This project will test whether heated yoga, sauna sessions, or a mindfulness app reduce symptoms in adults with at least moderate depression.
-
New treatment for depression in adolescents using brain stimulation
This study is testing a new brain stimulation treatment for depression in teens aged 14-19 who haven't tried antidepressants before, to see if it helps them feel better.
-
Comparing two types of brain stimulation for treatment-resistant depression
This study is testing if a new type of brain stimulation can help people with treatment-resistant depression just as well as a current method they already use.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.